Want to Invest in the Psychedelics Market? Here’s a Few Important Aspects to Consider

A few weeks ago, Psychedelic Capital held an event online that discussed various ways to carry out one’s due diligence with regard to investing in psychedelics. The discussion was hosted by Richard Skaife, a partner in the investment group Conscious Fund.

The experts on the panel included Zuber Lawler, partner; Jayashree Mitra, BDO Capital Advisors director of acquisitions and mergers; Michael Astone; and Ambria Capital director, Cody Shandraw.

We have seen the psychedelics market grow as more and more research comes to light regarding the various benefits these substances have, with the potential for many more discoveries. This particular sector is now in pursuit of capital with investors in countries such as Canada being able to buy stocks on various exchange platforms.

For infant industries that are just starting out, due diligence is especially important for an investor. Before making a decision on whether to invest in a psychedelic company, it’s recommended that you look into the reputation of the individuals who head the firms you may be interested in. This will inform you about the company’s credibility as well as the management’s record of performance in the industry.

In many industries, people tend to focus on results; however, when it comes to the medical space, potential investors may want to center on the science and technology that supports a psychedelic company’s field or research.

Also, keep in mind that you’ll also need skilled people working on your team, people who can conduct clinical trials and who have knowledge and experience working with drugs and chemicals.

Additionally, as a retail investor you should look into the share structure of companies you want to invest in before you actually invest. Studying a company’s debt agreements, understanding its obligations, and assessing its debt line and balance sheets is also recommended.

Furthermore, a prospective investor wishing to invest in any industry should also study a firm’s corporate governance bylaws as well as its shareholder agreements. This will provide you wkith a better outlook on the firm’s management structure.

Another panelist, MNP business advisor Mitchell Osak, explained that investors should know the value of what their funds can get for them, including looking over the capitalization table of the firm, or the share types offered to people and the firm’s ownership. In addition to this, before investing, all prospective investors should consult an advisor. This will ensure that you get value for any investment you make.

The functional mushrooms and psychedelics space has many noteworthy players. One of them is Pure Extracts Technologies Corp. (CSE: PULL). The plant-extracts company recently added a new vertical (functional mushrooms) to its interests and looks set to take pole position on matters of developing and commercializing products in this space.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.


Select A Month

PsychedelicNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 415.949.5050